Back to Search
Start Over
Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression.
- Source :
- Cell Death & Disease; Jan2022, Vol. 13 Issue 1, p1-14, 14p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 20414889
- Volume :
- 13
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Cell Death & Disease
- Publication Type :
- Academic Journal
- Accession number :
- 154873762
- Full Text :
- https://doi.org/10.1038/s41419-022-04520-6